Assura PLC Additional Listing (1162Y)

TIDMAGR

RNS Number : 1162Y

Assura PLC

04 September 2020

4 September 2020

Assura plc

Additional Listing

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, 213,319 New Ordinary Shares (the "New Shares") have been issued to the Assura plc Employee Benefit Trust in order to satisfy restricted share awards pursuant to the Performance Share Plan.

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 8 September 2020.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,662,174,038 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,662,174,038 .

For more information, please contact:

 
  Assura plc                         Tel: [phone] 
   Orla Ball, Company Secretary       E mail: [e-mail] 
   David Purcell, Head of Financial 
   Reporting 
  Finsbury                           Tel: [phone] 
   Gordon Simpson                     Email: [e-mail] 
   James Thompson 
 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2020, Assura's property portfolio was valued at GBP2,139 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSUPUPWBUPUGWC

(END) Dow Jones Newswires

September 04, 2020 09:34 ET (13:34 GMT)